Bowling Portfolio Management LLC Innoviva, Inc. Transaction History

Bowling Portfolio Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$9.33 - $12.48 $188,214 - $251,759	-20,173 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$10.33 - $14.49 $208,387 - $292,306	20,173 New	20,173 $211,000
Q2 2019 Jul 25, 2019	SELL	$13.1 - $14.95 $191,181 - $218,180	-14,594 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$13.69 - $20.06 $629 - $922	-46 Reduced 0.31%	14,594 $205,000
Q4 2018 Jan 17, 2019	BUY	$13.96 - $18.26 $204,374 - $267,326	14,640 New	14,640 $255,000
Q3 2018 Oct 18, 2018	SELL	$13.63 - $15.7 $1.61 Million - $1.85 Million	-117,977 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$13.44 - $17.59 $1.3 Million - $1.7 Million	96,882 Added 459.27%	117,977 $1.63 Million
Q1 2018 Apr 25, 2018	BUY	$13.8 - $16.99 $291,111 - $358,404	21,095 New	21,095 $352,000

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bowling Portfolio Management LLC with notifications on news.